The NIH MFM Network: How Science Gets Done
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
In the 1950's the standard treatment for premature infants with respiratory distress syndrome was 100% oxygen. An estimated 10,000 babies were blinded before the dangers of high oxygen treatment were fully understood. As physicians, many of us are only too aware that we still provide some treatments to patients because that's "the way we always have done it" or because "that is the way we were trained." In this segment, Dr. Spong describes some of the methodologies used to actually test the safety and efficacy of different treatment protocols to learn what works best.
Overview
In the 1950's the standard treatment for premature infants with respiratory distress syndrome was 100% oxygen. An estimated 10,000 babies were blinded before the dangers of high oxygen treatment were fully understood. As physicians, many of us are only too aware that we still provide some treatments to patients because that's "the way we always have done it" or because "that is the way we were trained." In this segment, Dr. Spong describes some of the methodologies used to actually test the safety and efficacy of different treatment protocols to learn what works best.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
NYHA FC and Finerenone Response: Clinical Trial Insights
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?